Therefore, sulfonylureas, as well as high-dose insulin therapy, could have an adverse effect on endothelial function in overweight or obese diabetics because of the selective insulin resistance, potentially resulting in endothelial dysfunction (Table 1). This evidence concerns the gene INS and endothelial dysfunction.